Home Contact Us Site Map
Search for:
Mercy Babies Classes News
Health Info Find a Job Find a Physician
Mercy Health Center
Oklahoma City
Quick Facts
Our Ministry
Foundation
Medical Services
Patient & Guest Services
Mercy Quality
Mercy Memorial
Health Center

Ardmore
Mercy Health
Network Clinics

Oklahoma City
Mercy NeuroScience
Institute

Oklahoma City
Oklahoma
Heart Hospital

Oklahoma City
 
Home > Mercy Health Center > Medical Services > Cancer Services > Mercy Women's Center 

Mercy Women's Center

Breast-Dedicated MRI

In January 2002, anticipating a revolution in breast imaging, Rebecca G. Stough, M.D. launched Oklahoma’s first comprehensive breast MRI program that incorporated MRI into routine clinical care.

After gaining her initial experience with three hundred patients undergoing breast MRI using a "breast coil" adaptor on a hospital body scanner, Dr. Stough switched to the Aurora breast-dedicated MRI located at Mercy Woman's Center in March 2003. Since that time, her experience in interpreting over one thousand breast MRIs per year has brought her into the limelight with this revolutionary technology.

 

Dr. Stough now serves on the Medical Advisory Board of Aurora Imaging, Inc. Where president and CEO Olivia Cheng, has stated, "Dr. Stough is one of the most experienced doctors in the world reading bilateral RODEO images...your team is truly outstanding and it's our honor to partner with you." Dr. Stough has also been a pioneer in the development of MRI-biopsy techniques, and she spends a good deal of time in worldwide travels, educating radiologists about breast MRI and MRI-guided biopsy technique (see our Newsletter Section). Dr. Stough serves as Clinical Director of Breast MRI of Oklahoma, LLC., while Dr. Carol O'Dell serves as Assistant Clinical Director, also having interpreted thousands of dedicated breast MRIs.
 

 

Dr. Stough (left) joined RODEO MRI pioneer, Dr. Steven Harms (right) in a trip to Taiwan, training radiologists in the interpretation of breast MRI

 

Dr. Carol O'Dell is a breast-dedicated radiologist who serves as Assistant Clinical Director of Breast MRI of Oklahoma

Indications for Breast MRI

Newly diagnosed breast cancer – mapping tumor size and extent to assist with lumpectomy vs. mastectomy decisions; checking for other areas of cancer in the same breast; screening the opposite breast for cancer not appreciated on conventional imaging

  • Diagnostic problems not settled by conventional imaging (multiple or inconclusive findings)

  • Judging the response to neoadjuvant chemotherapy

  • Distinguishing scar from recurrent cancer in lumpectomy patients

  • Searching for a primary cancer when axillary nodes are found to harbor malignancy

  • Evaluating for ruptured breast implants

  • Difficult diagnostic problems in patients with breast implants

  • Pre-operative study to rule out cancer prior to implants or reduction surgery

  • High Risk Screening (esp. in patients with dense tissue on mammography)

FOR FREQUENTLY ASKED QUESTIONS (FAQ) ABOUT BREAST MRI CLICK HERE.

Examples of Breast MRI Studies

The images below are somewhat limited for online viewing in that actual interpretations are performed on the computer by the radiologist who "pages through" hundreds of images, in multiple directions, or by creating 3-D "hologram". In addition, the images below are from the "early" days of breast MRI, RODEO™ . For a peek at the remarkable 3-D images we see today with spiralRODEO™ , CLICK HERE

Fig 1
Normal Breast MRI

Breast MRI includes many variations of the procured images. In this “MIP” version, the thin slices are re-assembled, creating a 3-D image on the computer that can be rotated in any direction. Only the gadolinium contrast is seen, so any worrisome “areas of enhancement” can be viewed from all angles. The branching white lines in this study (arrow) represent normal blood vessels. This negative study is a powerful statement that no cancer is present in this breast.
 

Fig 2
Small invasive cancer

In this subtraction view, only a thin slice of gadolinium contrast is seen, revealing a sub-centimeter invasive ductal carcinoma (arrow). A tumor this small will be invisible on mammography if it is surrounded by dense breast tissue. The advantage to finding cancer smaller than 1.0 cm is a cure rate in excess of 90% if lymph nodes are clear, along with infrequent use of chemotherapy.

Fig 3 (left)
Ductal carcinoma in Situ (DCIS)

While often called “early” breast cancer, DCIS can still spread throughout the ductal system and be more difficult to eradicate from the breast than many invasive cancers. Calcium is best detected on mammography, and it often leads to DCIS, but the extent of disease is frequently underestimated. In addition, many DCIS lesions do not develop calcium at all. Once again, Breast MRI is proving to be a very helpful adjunct in the detection of DCIS. In this patient’s breast, the DCIS forms both patchy and linear enhancements, and the problem proved to be much more extensive than believed from mammography alone.
 

 

 

 

Fig 4a (left) and 4b (right)
Axillary Adenopathy with Unknown Primary

This patient presented with an enlarged lymph node in her axilla (left: arrow) that proved to harbor metastatic cancer cells. While breast is the most likely site of origin, it is not always true, and this patient’s mammograms were normal. In years past, women presenting with malignant axillary nodes would undergo “blind” mastectomy, and it was not unusual for the breast to be normal on pathology exam (or, to find a small cancer that could have been handled easily with lumpectomy). Today, with breast MRI, one can see how clearly the subtraction view (right) shows a multifocal cancer (arrows) that was invisible on routine imaging studies.
 

(left to right) Fig 5a, Fig 5b, and Fig 5c
Extent of Cancer Grossly Underestimated by Mammography and Ultrasound.

Mammograms were low density in this patient, so when “invasive ductal carcinoma” was diagnosed from a solitary mass lesion, mammograms were felt to have accurately mapped the tumor pre-operatively. Ultrasound further confirmed a small, solitary tumor, so lumpectomy was advised and performed on the left breast. However, the surgeon was unable to obtain clear margins around the tumor after several attempts, so the procedure was ended, and breast MRI performed. In Figure 5a, one can see the large lumpectomy cavity (small arrows outline the bright fluid in the cavity), while an extensive area of residual cancer remains (large arrow). This residual cancer is best seen in the subtraction view (Figure 5b) as it extends throughout a large area (arrow) of the breast. However, the opposite breast (Figure 5c) had several areas of suspicious enhancement as well (arrow shows one example in the upper outer quadrant). Final diagnosis after bilateral mastectomy: extensive infiltrating lobular carcinoma, involving multiple quadrants in both breasts.

 

 

A member of the
Sisters of Mercy Health System